• Milan Scheidegger

    Active from 2021 - 2024

  • Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects

    2024
    Helena D. Aicher , Michael J. Mueller , Dario A. Dornbierer , Dila Suay , Claudius Elsner , Ilhui Wicki , Daniel Meling , Luzia Caflisch , Alexandra Hempe , Camilla Steinhart , Jovin Mueller , Robin Von Rotz , Birgit Kleim , Milan Scheidegger

  • Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-Dimethyltryptamine and harmine

    2023
    Dario A. Dornbierer , Laurenz Marten , Jovin Mueller , Helena D. Aicher , Michael J. Mueller , Martina Boxler , Michael Kometer , Davor Kosanic , Robin Von Rotz , Maxim Puchkov , Thomas Kraemer , Hans-Peter Landolt , Erich Seifritz , Milan Scheidegger

  • A pilot study of cerebral metabolism and serotonin 5-HT2A receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine

    2023
    Klemens Egger , Frederik Gudmundsen , Naja Støckel Jessen , Christina Baun , Sandra N. Poetzsch , Vladimir Shalgunov , Matthias M. Herth , Boris B. Quednow , Chantal Martin-Soelch , Dario A. Dornbierer , Milan Scheidegger , Paul Cumming , Mikael Palner

  • Pharmacokinetic and Pharmacodynamic Interaction of the Ayahuasca Constituents Harmine and Dimethyltryptamine (DMT) in the Rat Brain

    2023
    Klemens Egger , Frederik Gudmundsen , Naja Støckel Jessen , Christina Baun , Sandra Pötzsch , Vladimir Shalgunov , Matthias M. Herth , Boris B. Quednow , Chantal Martin-Soelch , Dario A. Dornbierer , Milan Scheidegger , Paul Cumming , Mikael Palner

  • Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey

    2022
    José Carlos Bouso , Óscar Andión , Jerome Sarris , Milan Scheidegger , Luís Fernando Tófoli , Emérita Sátiro Opaleye , Violeta Schubert , Daniel Perkins

  • Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans

    2021
    Paul Cumming , Milan Scheidegger , Dario A. Dornbierer , Mikael Palner , Boris B. Quednow , Chantal Martin-Soelch

  • Psychedelic Medicines: A Paradigm Shift from Pharmacological Substitution Towards Transformation-Based Psychiatry

    2021
    Milan Scheidegger , Beatriz CaiubyBeatriz Caiuby Labate , Clancy Cavnar

  • Ayahuasca use and reported effects on depression and anxiety symptoms: An international cross-sectional study of 11,912 consumers

    2021
    Jerome Sarris , Daniel Perkins , Lachlan Cribb , Violeta Schubert , Emerita Opaleye , José Carlos Bouso , Milan Scheidegger , Helena D. Aicher , Hana Simonova , Miroslav Horák , Nicole Galvão-Coelho , David Castle , Luís Fernando Tófoli

  • Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics

    2021
    Nicolas Langlitz , Erika Dyck , Milan Scheidegger , Dimitris Repantis
  • Show more
    9 papers